BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27956096)

  • 1. Policies towards hospital and GP competition in five European countries.
    Siciliani L; Chalkley M; Gravelle H
    Health Policy; 2017 Feb; 121(2):103-110. PubMed ID: 27956096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competition policy for health care provision in the Netherlands.
    Schut FT; Varkevisser M
    Health Policy; 2017 Feb; 121(2):126-133. PubMed ID: 27923494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competition policy for health care provision in Germany.
    Kifmann M
    Health Policy; 2017 Feb; 121(2):119-125. PubMed ID: 27908564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient choice, mobility and competition among health care providers.
    Brekke KR; Gravelle H; Siciliani L; Straume OR
    Dev Health Econ Public Policy; 2014; 12():1-26. PubMed ID: 24864380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competition policy for health care provision in France.
    Choné P
    Health Policy; 2017 Feb; 121(2):111-118. PubMed ID: 27993434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competition policy for health care provision in Portugal.
    Barros PP
    Health Policy; 2017 Feb; 121(2):141-148. PubMed ID: 28094051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranking sources of hospital quality information for orthopedic surgery patients: consequences for the system of managed competition.
    Bes RE; van den Berg B
    Patient; 2013; 6(2):75-80. PubMed ID: 23549928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managed care in four managed competition OECD health systems.
    Shmueli A; Stam P; Wasem J; Trottmann M
    Health Policy; 2015 Jul; 119(7):860-73. PubMed ID: 25776034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital merger control in Germany, the Netherlands and England: Experiences and challenges.
    Schmid A; Varkevisser M
    Health Policy; 2016 Jan; 120(1):16-25. PubMed ID: 26643437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of geographic market definition on the stringency of hospital merger control in Germany and the Netherlands.
    Varkevisser M; Schut FT
    Health Econ Policy Law; 2012 Jul; 7(3):363-81. PubMed ID: 22348390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competition policy for health care provision in Norway.
    Brekke KR; Straume OR
    Health Policy; 2017 Feb; 121(2):134-140. PubMed ID: 27916434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality competition and hospital mergers-An experiment.
    Han J; Kairies-Schwarz N; Vomhof M
    Health Econ; 2017 Dec; 26 Suppl 3():36-51. PubMed ID: 29285867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why healthcare providers merge.
    Postma J; Roos AF
    Health Econ Policy Law; 2016 Apr; 11(2):121-40. PubMed ID: 26055501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To what degree do patients actively choose their healthcare provider at the point of referral by their GP? A video observation study.
    Potappel AJC; Meijers MC; Kloek C; Victoor A; Noordman J; Olde Hartman T; van Dulmen S; de Jong JD
    BMC Fam Pract; 2019 Dec; 20(1):166. PubMed ID: 31787107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study.
    Vogler S; Vitry A; Babar ZU
    Lancet Oncol; 2016 Jan; 17(1):39-47. PubMed ID: 26670089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does managed competition constrain hospitals' contract prices? Evidence from the Netherlands.
    Douven R; Burger M; Schut F
    Health Econ Policy Law; 2020 Jul; 15(3):341-354. PubMed ID: 30973119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Netherlands: health system review.
    Schäfer W; Kroneman M; Boerma W; van den Berg M; Westert G; Devillé W; van Ginneken E
    Health Syst Transit; 2010; 12(1):v-xxvii, 1-228. PubMed ID: 21132996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Japanese healthcare: Fostering competition and controlling costs.
    Tiessen JH; Kato K
    Healthc Manage Forum; 2017 Jul; 30(4):175-180. PubMed ID: 28929871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choosing cooperation over competition; hospital strategies in response to selective contracting.
    van Ineveld M; van Wijngaarden J; Scholten G
    Int J Health Plann Manage; 2018 Oct; 33(4):1082-1092. PubMed ID: 30074272
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.